logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
30/03/2026
Goldman Sachs raises Ericsson's target stock price from 65 Swedish krona to 95 Swedish krona.
Latest
4 m ago
Bank of China: Achieve a post-tax profit of 257.936 billion yuan in 2025, a year-on-year increase of 2.06%.
4 m ago
AstraZeneca's rare disease innovative drug approved in China
4 m ago
AstraZeneca (AZN.O) announced that the China National Medical Products Administration has officially approved the use of selumetinib capsules (trade name: Koselugo) for the treatment of type 1 neurofibromatosis (NF1) in children and adults aged 3 and above with symptomatic and inoperable plexiform neurofibromas (PN). This is currently the first and only drug approved for the treatment of this patient population aged 3 and above in China.
4 m ago
Weiyuan Corporation: Abnormal fluctuation in stock trading, expected loss of 950-1050 million yuan in 2025.
5 m ago
Iran claims attack on US military radar station in UAE
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.